OOIR: Observatory of International Research

Papers

(The median citation count of Clinical Microbiology Reviews is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections	306
Extracutaneous sporotrichosis	265
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility	216
2025 Acknowledgment of CMR Reviewers	207
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance	156
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”	153
Integrating whole-genome sequencing into antimicrobial resistance surveillance: methodologies, challenges, and perspectives	150
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease	148
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	133
Viral infections and pathogenesis of glaucoma: a comprehensive review	124
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options	121
Progression of antibiotic resistance in Neisseria meningitidis	113
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities	109
The sex hormone-gut microbiome axis: mechanistic drivers of sex-disparate bacterial infection outcomes and precision clinical interventions	101
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus	101
Mechanisms of microbial colonization in biofilm-associated infections of hemodialysis catheters and advances in surface modification technologies	96
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves	95
Decontamination approaches and strategies for the prevention of sink drain-related healthcare-associated infections	95
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance	92
Review of BCG immunotherapy for bladder cancer	89
A review of post-exposure strategies for high-consequence viral pathogens in the laboratory	88
Canonical fact versus hypothesis testing to decipher transmission of non-tuberculous and tuberculous mycobacteria: a comparative review	85
Coxsackievirus A6 on the rise: epidemiology, pathogenicity, evolutionary dynamics, and antiviral strategy	84
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics	84
Neisseria gonorrhoeae vaccines: a contemporary overview	81

Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control	80
The black aspergilli ( Aspergillus niger complex) and their role in human, animal, and plant diseases	75
Congenital Syphilis: a Review of Global Epidemiology	72
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms	71
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen	70
Erratum for Cho et al., “Recent advances in therapeutic probiotics: insights from human trials”	69
Plasmodium vivax malaria in India: microbiological barriers to diagnosis, treatment, and elimination	67
Influence of fungi on epithelial homeostasis and role in inflammatory diseases	65
Gut microbiota-derived short-chain fatty acids (SCFAs): immunomodulatory effects and therapeutic potential in infections	61
Advances in medical and surgical management of Acanthamoeba keratitis: a comprehensive review	59
Serratia species as paratransgenic vehicles: potential applications in vector-borne disease control	59
Diagnosis, Management, and Future Control of Cholera	56
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease	55
Bacterial and fungal infections in persons who inject drugs	54
Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi	51
The ecological dynamics of skin microbiota in skin health and diseases	51
An unintended consequence: a review of iatrogenic central nervous system mold infections and outbreaks	51
Marburg virus disease: a comprehensive review	48
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections	45
Implementation of pathogen genomics in clinical microbiology laboratories	45
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	45
BCG therapy in bladder cancer and its tumor microenvironment interactions	45
Intravesical therapies for catheter-associated urinary tract infections: current approaches and future directions	44
Plasmids in Neisseria gonorrhoeae : drivers of DoxyPEP failure and an emerging threat for current therapy	42
Rapid and accurate testing for urinary tract infection: new clothes for the emperor	42
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome	41
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)	40
Harnessing the host response for precision infectious disease diagnosis	38
Mechanistic insights into the pathogenesis and therapeutic recalcitrance of Staphylococcus aureus osteomyelitis	37
Artemisinin-resistant malaria	37
Agnostic Sequencing for Detection of Viral Pathogens	37
Editorial Board	35
Convalescent plasma for COVID-19: planning for the next pandemic using the worldwide experience	35
The challenges of difficult-to-treat Acinetobacter infections	34
Pathogenesis of viral infections during pregnancy	33
Pneumocystis jirovecii pneumonia in people living with HIV: a review	32
IgY passive immunotherapy for pandemic preparedness: a One Health platform approach against pathogen X	32
COVID-19 therapeutics	32
Floods and infectious diseases: public health lessons from the 2024 southern Brazil disaster	31
From antibiotic to peptide siderophore conjugates as modular strategies against multidrug-resistant bacteria	31
An updated list of eumycetoma causative agents and their differences in grain formation and treatment response	30
The oral penems and carbapenems	29
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing	29
An update on Clostridioides difficile population structure and genomics	28
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease	27
Editorial Board	27
Updated Review onNocardiaSpecies: 2006–2021	27
Erratum for Gopalaswamy and Subbian, “The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tub	27
Human toxocariasis	26
Osteoarticular Mycoses	26

Invasive fusariosis	25
Clinical Microbiology Reviews : a 21st century vision	25
Coenzyme A metabolism in fungi: a new frontier in antifungal therapy	25
Schistosomiasis: cercarial finding and recognizing of human hosts as a prerequisite of invasion	24
From surveillance to stewardship: addressing antimicrobial resistance in Central Asia’s healthcare	23
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective	23
Narrative review on bacteria-derived metabolites in the pathogenesis of ulcerative colitis	23
Skin microbiota in atopic dermatitis: victim or executioner?	22
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities	22
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management	22
Host Immunity and Immunization Strategies for Clostridioides difficile Infection	22
The endothelium at the interface between tissues and Staphylococcus aureus in the bloodstream	21
Leptospira –host interactions: advancing next-generation vaccines and diagnostics	21
Ross River virus transmission, infection, and disease: two and a half decades of research progress—an updated cross-disciplinary review	20
Infection prevention and control in low- and middle-income countries: policy, practice, and implementation challenges in sub-Saharan Africa	19
Environmental and physiological factors influencing the survival of resistant Salmonella under infection-related gut conditions	19
Surveillance and prevention of infection in clinical xenotransplantation	18
The American Society for Microbiology’s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis	17
Advancements and challenges in antifungal therapeutic development	17
Current perspectives in the epidemiology and control of lymphatic filariasis	17
Masks and respirators for prevention of respiratory infections: a state of the science review	17
Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice	16
A call for the United States to continue investing in science	16
Human Listeriosis	15
Streptococcus pneumoniae β-lactam resistance: epidemiological trends, molecular drivers, and innovative control strategies in the post-pandemic era	15
Correction for Moreland et al., “Rapid and accurate testing for urinary tract infection: new clothes for the emperor”	15
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections	15
2023 Acknowledgment of CMR Reviewers	14
Neurological complications caused by SARS-CoV-2	14
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells	14
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies	13
Optimized use and performance of culture for periprosthetic joint infection diagnosis: a comprehensive literature review	13
A narrative review of coagulase-negative staphylococci in diabetic foot infections	12
American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis	12
Global emergence and rapid spread of Candidozyma auris (syn. Candida auris ): epidemiology, biology, and a	12
Fastidious or rarely isolated gram-negative rods with a particular focus on Kingella kingae	12